CollPlant Biotechnologies (CLGN) Long-Term Deferred Tax (2020 - 2022)

CollPlant Biotechnologies' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $20.1 million for Q4 2022.

• Quarterly Long-Term Deferred Tax rose 39.71% year-over-year to $20.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $20.1 million (up 39.71% YoY) and the FY2022 annual result came in at $20.1 million, up 39.71% from the prior year.
• Long-Term Deferred Tax was $20.1 million for Q4 2022 at CollPlant Biotechnologies, up from $14.4 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $20.1 million in Q4 2022 and bottomed at $14.4 million in Q4 2021.
• A 3-year average of $16.4 million and a median of $14.7 million in 2020 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax decreased 2.06% — and 2022, when it soared 39.71%.
• CollPlant Biotechnologies' Long-Term Deferred Tax stood at $14.7 million in 2020, then decreased by 2.06% to $14.4 million in 2021, then surged by 39.71% to $20.1 million in 2022.
• Business Quant data shows CLGN's Long-Term Deferred Tax at $20.1 million in Q4 2022, $14.4 million in Q4 2021, and $14.7 million in Q4 2020.